Hormone Therapy Is Linked to Cancer Risk
From Times Staff and Wire Reports
In the latest indictment of hormone replacement therapy, researchers at the Fred Hutchinson Cancer Research Center in Seattle have found that women taking an estrogen-progestin combination have an increased risk of ovarian cancer.
The women also underwent more endometrial biopsies for the diagnosis of cancer, according to the report in the Journal of the American Medical Assn.
Despite the increased risk, however, ovarian cancer remains a rare disease, the researchers said.
